ADVANTAGE In order to provide more accurate services,
the consultant in YIYONG Talent has focused on different subdivision.


Medical Device

Equipment, instruments, consumables and reagents etc.



Subdivision Areas


Medical devices refer to instruments, devices, appliances, external diagnostic reagents, calibrations, materials and other similar or related items directly or indirectly used for human body, including the required computer software. 


The purpose is to diagnose, prevent, guardianship, treat or alleviate the disease, and the purpose is to get utility in the way of physics. Department of Cardiology, surgery, Department of orthopedics, laboratory, intensive care unit, ultrasound, imaging, and so on. 


Main products: pacemakers, stents, spine and joint products, 3D printing technology, internet medical, imaging products, testing reagents and equipment, hemodialysis machines, operation room instruments, disposable consumables and other products.



Strength of Us


Sales & Marketing: Sales Director, Regional sales manager, Marketing director / manager, Product manager, Channel manager, etc.

Medical affairs: Director of government affairs, Market admittance manager, Clinical manager, Registration manager etc.

Production and R&D: Factory director,Operation manager,R&D director, Quality director, Technical director, Project manager, R & D Engineer, etc.

General function: HR, Finance, Legal affairs.



Customers' Appreciation


Medical devices are the best areas of subdivision we have done in healthcare,including IVD,high value consumptive material,rehabilitation equipment,dentistry,medical beauty etc.


All the candidates in the area we approached are the high potential talents in the industry.Every candidate we have served is very satisfied with our help.And the consultants of YiYong Talnts are also proud to be able to help them in this field.


Pharmacy

R&D, Production,and Sales & Marketing



Subdivision Areas


Rx, OTC, whether it is R&D, factory production, sales, or CRO related companies, YiYong Talents have a corresponding database of talent. In addition to traditional medicine, YiYong Talent will expand in the field of new drug research and development in the future, including biological medicine, traditional Chinese medicine and animal health.



Strength of US


Marketing: Sales Director, Regional sales manager, Marketing director / manager, Product manager, Channel manager, etc.

Medical affairs: Director of government affairs, Market admittance manager, Clinical manager, Registration manager etc.

Production and R&D: Factory director,Operation manager,R&D director, Quality director, Technical director, Project manager, R & D Engineer, etc.

General function: HR, Finance, Legal affairs.



Customers We've Served


MNC: Eli Lilly, AstraZeneca, Novartis, GlaxoSmithKline etc.;

Domestic enterprises: Yang Sen, Huarun, 999, Wuxi, Beida Pharmaceutical etc.


Biology

Biotechnology and Products



Subdivision Areas


Enterprises related to biotechnology, such as genes, proteins, stem cells and immunology,and the companies related to food, quarantine, agriculture, animal husbandry, scientific research, or clinical application.



Development of the Field


Biological science is the most rapid development, one of the most popular subjects, 50% in the study of biological science research team in the United States, whether international or domestic, investment of the biological sciences is very large, so the prospect of biological science is very optimistic.


In the national "11th Five-Year plan", the bio industry as a strategic industry is focused on development. In 2020, the national bioindustry value added exceeded 2 trillion yuan, accounting for more than 4% of GDP. It has become a pillar industry in the high technology field and the leading industry of the national economy.


Biological medicine and biological treatment in the field of biology, accounting for 1/4 of the total R & D. There are more than 900 projects in the United States, which are the most clinically treated, and there is no disease without biological treatment. According to technical means, single antibody is the most. Vaccine, cell therapy, gene therapy and so on, our country's market has accounted for 10% of biopharmaceuticals, compared with the scale is not big enough. Stem cells now have 13 products on the world, including Korea, Canada and so on. There is not a product listed in our country. The United States is the FDA cell beauty, when to put out by cell culture, cultivate a good go back again. At present, the development of CAR-T is relatively mature, and many research institutions and enterprises have been deeply involved at home and abroad.



Strength of US


Marketing: Sales Director, Regional sales manager, Marketing director / manager etc.

Medical affairs: Director of government affairs, Market admittance manager, Clinical manager, Registration manager etc.

Production and R&D: Factory director,Operation manager,R&D director, Quality director etc.

General function: HR, Finance, Legal affairs.


Chemistry & Health Care

Chemical raw materials and health care products.



Subdivision Areas


The upstream businesses of the pharmaceutical industry, such as API, intermediates and pharmaceuticals, as well as the surrounding industries of health care food and supplies, are listed by YiYong Talent in this subdivision sector.



Development of the Field


In the past few years, due to the expiration of the patents of several best sellers, the global pharmaceutical industry has undergone tremendous changes, and the rapid growth of raw material manufacturing has been promoted by the demand for low-cost substitutes. In 2013, the total output value of the global raw material drug market is 119 billion 700 million US dollars. It is expected to reach 185 billion 900 million US dollars by 2020, and the annual growth rate is expected to be 6.5%. The global market of API is mainly divided into non steroidal anti-inflammatory drugs, oncology drugs, diabetes drugs, cardiovascular drugs, central nervous system drugs, musculoskeletal drugs and other drugs. Most of the tumor drugs are biomaterials, which are expected to become the main growth point in the global market for raw materials.


Globally, the global market for API is divided into four major regions: North America, Europe, Asia Pacific and other regions. Due to the high demand for formulations and research and development, North America dominates the global market for raw materials. At present, the Asia Pacific region has attracted a large number of generic pharmaceutical manufacturers.


At present, China is already the world's largest producer and exporter of API. With the focus shifting of international pharmaceutical production and the cost reduction of multinational pharmaceutical companies, the focus of world chemical pharmaceuticals is shifting to developing countries. China's raw materials market in recent years, production and sales are growing, since 2011 the chemical raw materials industry sales income still maintain a rapid growth in 2013, 2014 and 2015 growth rate were 13.70%, 11.02% and 8.82%, showed a downward trend, but overall growth.


Health care food is a food that has specific health functions, that is suitable for a specific group of people to eat, and has the function of regulating body function and not treating diseases. In 2014, the scale of China's health products industry was 161 billion, with an annual growth of nearly 20%, and it is expected to break through 500 billion in 2020. Herbaceous, non herbaceous dietary supplements are considered to be the two fastest growing areas. Among the many subfields of dietary supplements, there are five high growth areas: bone and joints; skin care; gastrointestinal function; cardiovascular; antioxidation.


The market for health products in China is huge, but there are many competitors and low concentration in the market. Some enterprises in the industry do not attach importance to the quality of products, products and marketing means, and only rely on high intensity advertising input and false propaganda. As the industry moves towards standardization, consumers' cognition is constantly improving, and consumption habits are changing, companies with distinctive products and innovative marketing may come to the fore.



Strength of US


Marketing: Sales Director, Regional sales manager, Marketing director / manager etc.

Medical affairs: Director of government affairs, Market admittance manager, Clinical manager, Registration manager etc.


Medical Service

Hospitals, internet medical, nursing and old-age services.



Subdivision Areas

Hospitals, clinics and related medical institutions, as well as Internet related healthcare and medical data related enterprises in recent years, cover all functions besides IT.



Development of the Field


China is the world's largest population, with a huge population base and a rapidly growing aging population, which has brought a growing demand for medical services. At the national level, the input of medical services and the supply of essential factors have continued to increase to meet the needs of medical services. However, as the face of the developed countries such as Britain and the United States as our medical service system in medical service demand and supply both increased, is still "difficult and expensive" problem, the contradictory of medical service supply side and demand side.


Government input is the key driving force for the development of medical service industry. In recent years, the government's investment in the medical field has been increasing. The government's health expenditure has increased from 155 billion 253 million yuan in 2005 to 1 trillion and 57 billion 923 million yuan in 2014, the annual compound growth rate has reached 23.77%, and the proportion of total health expenditure has increased from 17.9% in 2005 to 30% in 2014. DDT CPA reported that the scale of China's medical service market will exceed 500 billion dollars in 2015, which will lead to the development of healthcare and related services.


At the end of September 2015, a total of 990 thousand medical institutions in China, including 13304 public hospitals, private hospitals 13600. Although the number of public hospitals accounts for only 1.34% of the total medical service institutions, it has taken over 1/3 of the medical services. There will be a lot of opportunities to strengthen the ability of the private hospitals to provide service. At the same time, the appropriate technology of TCM will enter the traditional Chinese medicine hall and the national medical hall at the grass-roots medical institutions at a faster speed, and Chinese medicine will quickly enter more and more ordinary people's homes to promote the healthy dream of the whole nation and the Chinese dream.


The development of medical service Internet healthcare is a trend, because now all industries are based on Internet big data, and the medical industry is no exception, which is a development direction. Before the development of these internet medical enterprises, including good doctors and dun Xiang Garden, there are many bright spots and breakthroughs in the development of these ten years. The country has three, two, first level hospitals, community service centers, outpatients and clinics, and different levels of physical medical institutions can provide different services. Internet hospitals, cloud hospitals, and other so-called network hospitals, can achieve innovative profit models, and can also bring more convenient medical services to the public.


In addition to the convenience of the Internet, internet medical services can also cooperate with related health services, such as the combination of commercial health insurance. The more innovation of the Internet in the future will produce "new medical", a new type of business and integrated with the entity medical institutions.


China has a trend of rapid population aging, and nursing and pension industry is the inevitable product of social development. This industry is not only for the elderly's life, but also for the elderly to provide facilities, commodities, special services and other contents. It is a collection of various industries for the elderly. In 2014, China's pension industry market capacity of 4 trillion and 100 billion, accounted for 6.44% of GDP, but with the United States in 22.3%, the proportion of 20.1%-36.8% compared to Europe, there are still a large gap, is expected to 2020, China's pension industry market space will reach 7 trillion and 700 billion, to 2030 is expected to achieve 22 trillion and 300 billion.



Strength of US 


Director of the hospital, the Chief doctor, the Chief physician, the Head nurse, the Purchase, the Government's relation etc.



Representative Enterprise


Spring Rain Doctor, Ping An Good Doctor, Zhang Qiang Doctor Group, AierChina and so on.


Life Science

Analytical research instrument.



Subdivision Areas

In the early years, life sciences enterprises mainly expand their businesses in universities and research market. With the trend of clinical change, YiYong Talent was starting to pay close attention to related fields. It mainly includes: PCR and all kinds of products related to gene analysis, proteomics and cell processing, as well as mass spectrometry, chromatography, spectroscopy and environmental analysis instruments.



Development of the Field


The cycle of input and output in the field of life science is long, and investment in this field is affected by government budgets. In addition, due to the strong professionalism of life sciences and many different research fields, plus life sciences and medicine, chemistry, electronics and other disciplines are closely linked, interdisciplinary and cross industry links are more, the complexity of the industry is also very obvious. In 2014, the global market for life science instruments sold more than $40 billion and increased at a rate of 6%.


Life science for many years, Chinese government always attaches great importance to the development of the life sciences industry, both in 11th Five-Year and 12th Five-Year, including 13th Five-Year, government investment in the life sciences industry has been great. The molecular diagnosis market is still one of the hotspots in the field of life science. Since 2014, China's molecular diagnostic market has increased by more than 20%. In another life science hot spot, biological breeding with transgenic technology as the core is the leading role in the development of biological agriculture in China. The rapid development of these hot areas has led to the procurement requirements of related research tools, such as gene sequencing instrument, PCR instrument and other molecular cell biological instruments.


The media predicted that nearly three years with the rapid development of molecular diagnostics, bio medicine and other fields, fluorescence quantitative PCR instrument, second generation sequencing (NGS) / third generation sequencing (3GS), chip, PCR, CE sequencing, PCR and other digital genomics related instruments; instrument of protein separation and analysis equipment, ELISA, Western blot and protein chip proteins; flow cytometry, microscopy, cell biology instruments will have a larger market size.



Strength of US 


Sales & Marketing: Sales Director, Regional sales manager, Marketing director / manager, Product manager, Channel manager, etc.

Medical affairs: Director of government affairs, Market admittance manager, Clinical manager, Registration manager etc.

Production and R&D: Factory director,Operation manager,R&D director, Quality director, Technical director, Project manager, R & D Engineer, etc.

General function: HR, Finance, Legal affairs.



Representative Enterprise


Thermo Fisher、PerkinElmer、Eppendorf、BioTek Instruments and so on.

小丽
地址:中国 · 深圳 · 宝安中心区 · 宝源路F518时尚创意园15栋3层
全国统一客服电话:
8621-3412  0222